News for EOFLOW Co.,Ltd. (294090.KQ)

Insulet Corporation (PODD) has announced a significant legal triumph following a jury verdict in its favor in the case against EOFlow Co., Ltd. and other defe

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless insulin pump[/url] technology with its Omnipod® brand of pro

Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the...

Rutherford, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on...

/PRNewswire/ -- The "Global Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes,...

The global Diabetes Care Devices market size is expected to reach USD 57.67 billion by 2030 and exhibit a CAGR of 8.7% in the forecast period (2023−2030),...

/PRNewswire/ -- The insulin pump market size is expected to increase by USD 5,465.96 million from 2022 to 2027, registering a CAGR of 16.25%, according to the...

/PRNewswire/ -- The wearable patch market is set to grow by USD 5,653.7 million from 2022 to 2027, progressing at a CAGR of 12.02% during the forecast period....

/PRNewswire/ -- In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes...

Medtronic's MiniMed 780G and acquisition of EOFlow could inspire growth, under fierce competition. MDT stock is rated as a hold. Read here for more detail.

/PRNewswire/ -- The

The Ketone Supplements market is witnessing positive growth owing to the increasing popularity of ketogenic diets for weight loss and gaining strength,...